Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CGC stock hub

Canopy Growth Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CGCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
428.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CGC
In the news

Latest news · CGC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-48.5
P25 -105.6P50 -46.5P75 -3.1
ROIC-7.2
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CGC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
CAD
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001737927
Company name
Canopy Growth Corporation
Country
Canada
Country code
US
Cusip
138035100
Employees
960
Employees Change
-69%
Employees Change Percent
-6.71
Enterprise value
$343.4M
Exchange
NASDAQ
Financial currency
CAD
First seen
2026-05-09
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA1380357048
Last refreshed
2026-05-10
Market cap
$428.4M
Market cap category
Small-Cap
Price
$1.11
Price currency
USD
Rev Per Employee
211,497.57x
Sector
Healthcare
Sic
2833
Symbol
CGC
Website
https://www.canopygrowth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-55.6%
EV Sales Forward
1.02x
EV/Sales
1.69x
FCF yield
-14.71%
P/B ratio
0.77x
P/S ratio
2.11x
PS Forward
1.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-17.25%
EBITDA Margin
-3.14%
Gross margin
26.56%
Gross Profit
$53.9M
Gross Profit Growth
-12.12%
Gross Profit Growth Q
-10.92%
Gross Profit Growth5 Y
-9.11%
Net Income
$-238.2M
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Pretax Margin
-117.14%
Profit Margin
-117.31%
Profit Per Employee
$-248,110
ROA
-2.64
Roa5y
-4.78
ROCE
-4.77
ROE
-48.5
Roe5y
-76.97
ROIC
-7.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-25.05%
Cagr1y
-13.96%
Cagr3y
-56.4%
Cagr5y
-66.23%
EPS Growth Quarters
3
EPS Growth Years
2
Revenue Growth
0.59x
Revenue Growth Q
-0.29x
Revenue Growth Years
0x
Revenue Growth3 Y
-8.78x
Revenue Growth5 Y
-11.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.25
Assets
$806.8M
Cash
$270.9M
Current Assets
$383.8M
Current Liabilities
$71.9M
Debt
$186.1M
Debt EBITDA
$42.66
Debt Equity
$0.34
Equity
$553M
Interest Coverage
-1.16
Liabilities
$253.8M
Long Term Assets
$423M
Long Term Liabilities
$181.9M
Net Cash
$84.9M
Net Cash By Market Cap
$19.81
Net Debt Equity
$-0.15
Tangible Book Value
$462.7M
Tangible Book Value Per Share
$1.26
WACC
15.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.34
Inventory Turnover
2.08
Net Working Capital
$49.4M
Quick ratio
4.11
Working Capital
$311M
Working Capital Turnover
$0.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-163.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
-94.4%
1Y total return
-13.95%
200-day SMA
1.22
3Y total return
-91.72%
50-day SMA
1.07
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.56%
All Time High
592.5
All Time High Change
-99.81%
All Time High Date
2018-10-16
All Time Low
0.77
All Time Low Change
44.16%
All Time Low Date
2025-04-09
ATR
0.08
Beta
2.39
Ch YTD
-2.63
High
1.14
High52
2.38
High52 Date
2025-12-18
High52ch
-53.36%
Low
1.11
Low52
0.84
Low52 Date
2026-03-30
Low52ch
31.6%
Ma50ch
3.84%
Premarket Change Percent
-0.44
Premarket Price
$1.13
Price vs 200-day SMA
-9.02%
RSI
49.6
RSI Monthly
34.54
RSI Weekly
46.97
Sharpe ratio
0.36x
Sortino ratio
0.7
Tr YTD
-2.63
Tr1m
11.88%
Tr1w
-1.77%
Tr3m
0.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

7
MetricValue
Analyst Count
1
Analyst Ratings
Hold
Earnings EPS Estimate
$-0.06
Earnings Revenue Estimate
53,260,000x
Earnings Revenue Estimate Growth
16.43x
Operating Income
$-35M
Operating margin
-17.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
380,531,593%
Float Percent
100.71%
Net Borrowing
-155,401,777.6
Shares Insiders
0.08%
Shares Institutions
11.37%
Shares Out
377,862,634
Shares Qo Q
26.1%
Shares Yo Y
163.03%
Short Float
7.07%
Short Ratio
3.19
Short Shares
7.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-51.4M
Average Volume
14,697,990.5x
Bv Per Share
1.5
CAPEX
$-5.4M
Ch10y
-94.4
Ch1m
11.88
Ch1w
-1.77
Ch1y
-13.95
Ch3m
0.91
Ch3y
-91.72
Ch5y
-99.56
Ch6m
-5.13
Change
-1.77%
Change From Open
-1.77
Close
1.13
Days Gap
0
Depreciation Amortization
28,738,524.6
Dollar Volume
5,032,094
Earnings Date
2026-05-29
Earnings Time
bmo
EBIT
$-35M
EBITDA
$-6.4M
EPS
$-0.99
F Score
4
FCF
$-63M
FCF EV Yield
-18.35x
FCF Per Share
$-0.17
Financing CF
196,803,343
Fiscal Year End
March
Goodwill
34,764,639.2
Income Tax
$876,656
Investing CF
14,801,768
Is Primary Listing
0
Is Spac
No
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Last Split Date
2023-12-20
Last Split Type
Reverse
Last10k Filing Date
2025-05-30
Ma150
1.18
Ma150ch
-5.85%
Ma20
1.15
Ma20ch
-3.39%
Net CF
152,731,344
Next Earnings Date
2026-05-29
Open
1.13
Optionable
Yes
Position In Range
0
Post Close
1.11
Postmarket Change Percent
1.21
Postmarket Price
$1.12
Ppne
208,506,638.4
Pre Close
1.13
Price Date
2026-05-08
Ptbv Ratio
0.93
Relative Volume
0.31x
Revenue
203,037,663x
SBC By Revenue
-5.73x
Share Based Comp
-11,624,074
Tax By Revenue
0.43x
Tr6m
-5.13%
Volume
4,533,418
Z Score
-12.66
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CGC pay a dividend?

Capital-return profile for this ticker.

Performance

CGC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-14.0%
S&P 500 1Y: n/a
3Y total return
-91.7%
S&P 500 3Y: n/a
5Y total return
-99.6%
S&P 500 5Y: n/a
10Y total return
-94.4%
S&P 500 10Y: n/a
Ownership

Who owns CGC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.4%
Float: +100.7% of shares outstanding
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+7.1%
3.2 days to cover
Y/Y dilution
+163.0%
Negative means the company is buying back shares.
Technical

CGC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.6
Neutral momentum band
Price vs 200-day MA
-9.0%
50/200-day relationship not available
Beta (5Y)
2.39
More volatile than the market
Sharpe ratio
0.36
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CGC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CGC stock rating?

Canopy Growth Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CGC analysis?

The full report lives at /stocks/CGC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CGC?

The latest report frames CGC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CGC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.